Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia

AIMS: Thrombocytopenia is often associated with chronic liver disease. Lusutrombopag is a small molecule thrombopoietin receptor agonist designed to temporarily increase the platelet count in patients with chronic liver disease for whom elective invasive procedures are planned. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Toru, Okoshi, Marina, Tomiyoshi, Kei, Kojima, Yuichi, Horigome, Ryoko, Imai, Michitaka, Nozawa, Yujiro, Iwanaga, Akito, Sano, Tomoe, Honma, Terasu, Yoshida, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849762/
https://www.ncbi.nlm.nih.gov/pubmed/30602063
http://dx.doi.org/10.1111/hepr.13305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849762/
https://www.ncbi.nlm.nih.gov/pubmed/30602063
http://dx.doi.org/10.1111/hepr.13305

Ejemplares similares